International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials

Published on: 11 August, 2020

Costa LJ, Derman BA, Bal S, Sidana S, Chhabra S, Silbermann R, Ye JC, Cook G, Cornell RF, Holstein SA,  Shi Q, Omel J, Callander NS, Chng WJ, Hungria V, Maiolino A, Stadtmauer E, Giralt S, Pasquini M, Jakubowiak AJ, Morgan GJ, Krishnan A, Jackson GH, Mohty M, Mateos MV, Dimopoulos MA, Facon T, Spencer A, San Miguel J, Hari P, Usmani SZ, Manier S, McCarthy P, Kumar S, Gay F, Paiva B. International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials. Leukemia. 2021 Jan;35(1):18-30. Epub 2020 Aug 11.

Related Themes

Related Team Members

Professor Gordon Cook

Clinical Director and Oncology Theme Lead

Share

Facebook
Twitter
LinkedIn